Test Directory

Test Code
AIFA
Test Name
Intrinsic Factor Abs, Serum
CPT Codes
86340
Expected Turnaround Time
2 - 4 days
Clinical Utility

Intrinsic factor is a glycoprotein (produced by the parietal cells of the stomach) that is required for the absorption of vitamin B12 from the diet.During digestion, stomach acids dissociate B12 from food and intrinsic factor binds to it and allows it to be absorbed in the small intestine. Conditions that impair intrinsic factor production lead to B12 malabsorption and deficiency. Laboratory findings for B12 deficiency include decreased serum B12 levels, increased methylmalonic acid and megaloblastic anemia. Impaired hemoglobin synthesis associated with B12 deficiency is characterized by abnormal maturation of erythrocyte precursors in the bone marrow, which results in the presence of megaloblasts with hypersegmented neutrophils and decreased erythrocyte survival. Vitamin B12 deficiency is also associated with neurological abnormalities.A leading cause of vitamin B12 deficiency is pernicious anemia (PA) caused by intrinsic factor deficiency. The condition is referred to as "pernicious" because it is clinically silent initially and only becomes manifest when patients experience generalized symptoms, such as weakness, diminished energy and (less commonly) dyspepsia. The incidence of PA increases with age and is relatively rare in individuals younger than 30 years of age. The highest prevalence is seen in Northern Europeans, although PA has been reported in virtually every ethnic group. PA can be caused by pathologic conditions that damage or remove a portion of the stomach's parietal cells, including bariatric surgery, gastric tumors, gastric ulcers, and excessive consumption of alcohol. Autoimmune ABG is caused by CD4 T cell-mediated autoimmune response directed against the gastric H/K-ATPase.11 Diagnosis of autoimmune PA relies on histologically proven atrophic body gastritis, megaloblastic anemia, B12 deficiency, and antibodies to intrinsic factor and to gastric parietal cells.10 Antiparietal cell antibodies are found in 90% of patients with PA, but have low specificity and are seen in atrophic gastritis without megaloblastic anemia as well as in various autoimmune disorders. Anti-intrinsic factor antibodies are less sensitive, being found in only 60% of patients with PA, but they are considered highly specific for PA. Laboratory diagnosis is further supported by increased levels of fasting gastrin and decreased levels of pepsinogen I. Epidemiological evidence and genetic studies suggest that PA has a significant heritable component and leucocyte antigen-DR genotypes suggest a role for genetic susceptibility. Long-standing Helicobacter pylori infection may play a predisposing role in many patients in whom the active infectious process has been gradually supplanted by an autoimmune disease that terminates in a burned-out infection and the irreversible destruction of the gastric body mucosa. PA is frequently associated with autoimmune thyroid disease (40%) and other autoimmune disorders, such as diabetes mellitus (10%), as part of the autoimmune polyendocrine syndrome. PA incidence is also increased in patients with primary biliary cirrhosis compared to controls. Autoimmune gastritis may predispose to gastric carcinoid tumors or adenocarcinomas.

Specimen and Container Info

Specimen Type: Serum

Collection Container: Gold Top, Serum Separator or Red Top, Plain

Desired Specimen Volume: 2 mL

Collection Instructions
  1. Collect gold top, serum separator tube or red top, plain via venipuncture.
Processing and Submission Instructions
  1. Separate serum from cells.
  2. Transfer 2 mL of serum to a clear aliquot tube.
Patient Preparation

No specimen should be collected from a patient currently undergoing B12 therapy less than one week after the last B12 injection.

Transport Instructions

Transport to the laboratory frozen. 

Stability Requirements

Room Temperature

14 days

Refrigerated

14 days

Frozen

14 days

Freeze/Thaw Cycles

 Stable x3

Causes for Rejection

Plasma specimen

Methodology
Immunochemiluminometric Assay (Icma)
Reference Intervals

0.0−1.1 AU/mL

Alternate Names
Intrinsic Factor Blocking Antibodies
Reference Lab
Labcorp Of America Holdings
Testing Schedule
Monday-Friday